World Asthma Day 2024 - Asthma Education Empowers

World Asthma Day 2024 - Respiratory Research
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Despite strides in therapeutic development for asthma management, its morbidity and mortality persistently rise, particularly burdening low- and middle-income countries. To address this pressing need for deeper insight into asthma pathogenesis and therapeutic targets, Respiratory Research presents two focused issues that showcase cutting-edge discoveries in the field.  The findings presented in both collections, “Asthma: Towards a Cure” and “Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease” will provide exciting discoveries furthering education and speaking to the theme of this year’s World Asthma Day – Asthma Education Empowers.

The first themed collection, "Asthma: Towards a Cure," compiles manuscripts delving into innovative science aimed at addressing the unmet challenge of managing and ultimately curing asthma. Within this collection, authors unveil novel biomarkers predicting therapeutic responses to both emerging and established treatments. Encompassing fundamental, translational, and clinical studies, these manuscripts not only disseminate new approaches but also strive to influence clinical practice and policy.

The second issue, "Human Precision Cut Lung Slices: an Ex Vivo Platform for Therapeutic Target Discovery and Drug Testing in Lung Disease,” spotlights the utility of an experimental platform mirroring the complexities of the in vivo lung environment. While precision cut lung slices (PCLS) have been utilized in respiratory research since the late 1970s, recent innovations have propelled their acceptance and expanded their applications across various domains. From toxicology and drug discovery to lung cancer biology and respiratory pathogen exposure, PCLS derived from both animal models and human lungs have significantly enhanced our understanding of integrated cellular responses, elucidating fundamental mechanisms in lung biology and providing a platform for therapeutic discovery.

Given the global impact of asthma, Respiratory Research is committed to sharing breakthroughs in asthma research, thereby contributing to the advancement of global health initiatives and providing education to both the scientific community and the general public to empower everyone to combat this disease.

 

Cynthia Koziol-White and Reynold A. Panettieri, Jr.

Rutgers University, New Brunswick, New Jersey USA

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Asthma
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Respiratory Tract Diseases > Asthma

Related Collections

With collections, you can get published faster and increase your visibility.

Asthma: Towards a Cure

RR seeks manuscripts that address cutting-edge science addressing the unmet need to manage and cure asthma. Such manuscripts could include novel biomarkers that predict therapeutic responses to novel or current therapy. Fundamental, translational, and clinical studies are encouraged that can promote the dissemination and implementation of novel approaches to change clinical practice and policy.

Publishing Model: Open Access

Deadline: Ongoing

Pleural Disease: advances in pathology, diagnosis and therapeutic approach

Due to the ever growing evidence base into the mechanisms, pathogenesis and management of the myriad conditions affecting the pleural space, as well as the growth of highly specialist physician-led interventions, pleural disease is now considered a distinct and important subspecialty of respiratory medicine. The burden of pleural disease is considerable, with pleural effusions alone estimated to affect over million people per year worldwide. The range of pleural disease is broad, including malignant and benign conditions, curative or palliative and acute or chronic, presenting as entities in themselves or as part of a wide-ranging number of other medical and surgical conditions. Pleural disease may therefore present to respiratory physicians or to many other healthcare professionals, including surgery, general internal medicine, oncology, infectious diseases and oncology hence the crucial requirement for interspecialty and multidisciplinary involvement. Interventions such as thoracoscopy, image-guided pleural biopsy and indwelling pleural catheters play a key role in pleural specialist practice, with thoracic ultrasound being the true revolutionary tool in the pleural physician’s arsenal. To coincide with the above, over the past decade there has been a surge in the number of major studies, many of them randomised controlled trials with patient-centred outcomes, focusing on conditions such as pneumothorax, malignant pleural effusion, mesothelioma and pleural infection. Their results have in many respects been practice changing, and provided a range of new treatment options to be offered to patients with pleural conditions. This wave of robustly designed, multicentre studies will hopefully continue over the coming years. Despite this substantial amount of high quality data, there remain significant gaps in the literature to be addressed, such as those relating to the phenotyping and optimal treatment of pleural infection, early diagnosis of mesothelioma, the optimal palliative strategy in malignant pleural effusion as well as the pathophysiology and mechanisms underpinning the development of pleural conditions. This collection will welcome original articles or reviews on the clinical and pre-clinical diagnosis and management of pleural diseases and we look forward to your important contributions.

Publishing Model: Open Access

Deadline: Ongoing